Learn How Doctors Make Treatment Decisions

Most pharma insight stops at what was prescribed. Konsuld reveals how those decisions were formed.

Where AI Meets Clinical Peer Collaboration

Konsuld is not a standalone clinical AI tool. It’s a clinical collaboration platform where doctors discuss AI-recommended treatment insights with other clinicians.

AI surfaces evidence. Peers provide context. Decisions take shape.

This combination creates a new, authentic signal into clinical thinking.

Konsuld enables pharma teams to see:

How doctors interpret AI recommendations
Where peers agree, challenge, or refine guidance
Which factors influence confidence or hesitation
How treatment options are framed in real practice

Book a Demo

Clinicians across specialties that use Konsuld® to collaborate securely, compare approaches, and access at the point-of-care, curated AI insights supported by evidence and peer experience.

Download the Lung Cancer Signals Report

Get insight into how physicians use AI and peer collaboration to navigate complex treatment decisions.

Download Report

Built for Pharma Teams

Competitive Intelligence

See how therapies are discussed organically

Innovation

Observe unmet needs as they emerge

Commercial Strategy

Understand peer-validated treatment positioning

Medical Affairs

Identify real clinical questions and evidence gaps

Trusted Across Leading Healthcare Organizations

Florida Cancer Specialists & Research Institute

As Featured In…

Benefits of AI-powered collaboration for life sciences companies

30% faster clinical trial recruitment and 10-15% improved data accuracy¹
20% more accurate drug efficacy assessments and improved regulatory support via real-world evidence²
10-20% increase in reimbursement rates via value-based care evidence³

1. Fultinavičiūtė, U. (2022). AI benefits in patient identification and clinical trial recruitment has challenges in sight. Clinical Trials Arena. 2. Deloitte Insights. (2020) Intelligent clinical trials: Transforming through AI-enabled engagement. Deloitte Centre for Health Solutions. 3. Sherman, R. E. et al. (2016). Real-World Evidence – What Is It and What Can It Tell Us? New England Journal of Medicine, 375(23), 2293-2297. 4. Sorenson, C. et al. (2008). Ensuring Value for Money in Health Care: The Role of Health Technology Assessment in the European Union. European Observatory on Health Systems and Policies.

Join Konsuld® and impact your company’s future growth

Konsuld combines:

Accelerate innovation: foster cutting-edge research
Enhance data utilization: maximize real-world evidence
Improve patient outcomes: Support comprehensive care
Expand market data: drive adoption of new therapies
Strengthen industry leadership: lead the transformation of healthcare
Foster a collaborative ecosystem: build strategic alliances